Published in Neurol Res on October 01, 1995
Towards non-thrombogenic performance of blood recirculating devices. Ann Biomed Eng (2010) 0.98
Effects of myocardial contractility on microemboli production by mechanical heart valves in a bovine model. Tex Heart Inst J (2000) 0.79
[Turbulence and high intensity transient signals (HITS) as a parameter for optimum orientation of mechanical heart valves]. Z Kardiol (2001) 0.75
White-coat hypertension as a cause of cardiovascular dysfunction. Lancet (1996) 4.68
Termination of trial of streptokinase in severe acute ischaemic stroke. MAST Study Group. Lancet (1995) 4.50
Is hyperglycaemia an independent predictor of poor outcome after acute stroke? Results of a long-term follow up study. BMJ (1997) 3.88
Anticardiolipin antibodies in an unselected stroke population. Lancet (1994) 3.66
Interatrial septal abnormalities and stroke: a meta-analysis of case-control studies. Neurology (2000) 3.64
Influence of cholesterol on survival after stroke: retrospective study. BMJ (1997) 3.64
Twelve-year comparison of a Bjork-Shiley mechanical heart valve with porcine bioprostheses. N Engl J Med (1991) 3.31
The present role of coronary artery surgery. Practitioner (1982) 3.08
Poor accuracy of stroke scoring systems for differential clinical diagnosis of intracranial haemorrhage and infarction. Lancet (1994) 3.03
Thrombolysis in stroke patients aged 80 years and older: Swiss survey of IV thrombolysis. Neurology (2005) 2.69
Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial): randomised controlled trial. Lancet (2004) 2.51
Feasibility and safety of moderate hypothermia after massive hemispheric infarction. Stroke (2001) 2.26
Thrombolysis outcomes in acute ischemic stroke patients with prior stroke and diabetes mellitus. Neurology (2011) 2.24
5-year outcome of an interventional strategy in non-ST-elevation acute coronary syndrome: the British Heart Foundation RITA 3 randomised trial. Lancet (2005) 2.15
Pneumonia and urinary tract infection after acute ischaemic stroke: a tertiary analysis of the GAIN International trial. Eur J Neurol (2004) 2.12
Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group. Mov Disord (2000) 2.10
Low-dose preoperative aspirin therapy, postoperative blood loss, and transfusion requirements. Ann Thorac Surg (1990) 2.07
Hyperinsulinism and cerebral microangiopathy. Stroke (1996) 2.03
Nurse led shared care for patients on the waiting list for coronary artery bypass surgery: a randomised controlled trial. Heart (2001) 1.93
Consensus on microembolus detection by TCD. International Consensus Group on Microembolus Detection. Stroke (1998) 1.87
Comparison of neurological scales and scoring systems for acute stroke prognosis. Stroke (1996) 1.83
Heparin-induced platelet dysfunction and cardiopulmonary bypass. Ann Thorac Surg (2000) 1.75
Cerebral vasoconstriction in vasovagal syncope: any link with symptoms? A transcranial Doppler study. Circulation (2001) 1.72
Respiratory dysfunction after uncomplicated cardiopulmonary bypass. Ann Thorac Surg (1993) 1.66
Ischaemic stroke in young adults: predictors of outcome and recurrence. J Neurol Neurosurg Psychiatry (2005) 1.58
A new porcine bioprosthesis: in vitro and in vivo evaluation. Life Support Syst (1985) 1.55
Gender differences in spontaneous cervical artery dissection. Neurology (2006) 1.52
Impaired hemodynamics and neural activation? A fMRI study of major cerebral artery stenosis. Neurology (2003) 1.48
Selfotel in acute ischemic stroke : possible neurotoxic effects of an NMDA antagonist. Stroke (2000) 1.47
Differentiation between intracerebral hemorrhage and ischemic stroke by transcranial color-coded duplex-sonography. Stroke (1998) 1.45
In vitro calcification of bioprosthetic heart valves: report of a novel method and review of the biochemical factors involved. J Heart Valve Dis (1992) 1.45
Functional outcome measures in contemporary stroke trials. Int J Stroke (2009) 1.43
C-reactive protein and outcome after ischemic stroke. Stroke (1999) 1.42
Plasma albumin and haemodilution: the problem of interpretation in sequential studies. Ann Clin Biochem (1989) 1.42
Updated guidelines for the management of Parkinson's disease. Hosp Med (2001) 1.41
Correlation of Parkinson's disease severity and duration with 123I-FP-CIT SPECT striatal uptake. Mov Disord (2000) 1.40
Twenty year comparison of a Bjork-Shiley mechanical heart valve with porcine bioprostheses. Heart (2003) 1.39
Effect of a gonadotropin releasing hormone analog on cerebral hemodynamics in premenopausal women. Climacteric (2005) 1.38
Phase IIa randomized double-blind, placebo-controlled study of inhaled apomorphine as acute challenge for rescuing 'off' periods in patients with established Parkinson's disease. Eur J Neurol (2013) 1.38
Respiratory dysfunction following cardiopulmonary bypass: verification of a non-invasive technique to measure shunt fraction. Respir Med (1993) 1.38
Clinical relevance of intracranial microembolic signals in patients with left ventricular assist devices. A prospective study. Stroke (1996) 1.37
Clinical experience with excitatory amino acid antagonist drugs. Stroke (1995) 1.33
Randomized trial of graded compression stockings for prevention of deep-vein thrombosis after acute stroke. QJM (2000) 1.27
Future challenges facing the development of specific active-site-directed synthetic inhibitors of MMPs. Biochimie (2005) 1.26
Mechanism of ischemic infarct in spontaneous carotid dissection. Stroke (2004) 1.25
Endocarditis as a manifestation of Chlamydia B infection (psittacosis). Br Heart J (1977) 1.24
Problematic gambling on dopamine agonists: Not such a rarity. Mov Disord (2006) 1.20
A randomised, controlled pilot study to investigate the potential benefit of intervention with insulin in hyperglycaemic acute ischaemic stroke patients. Cerebrovasc Dis (2006) 1.15
Hemorrhagic transformation in acute ischemic stroke. The MAST-E study. MAST-E Group. Stroke (1999) 1.12
Recanalisation of cerebral venous thrombosis. J Neurol Neurosurg Psychiatry (2003) 1.11
Anticoagulation monitoring with transcranial Doppler. Lancet (1994) 1.11
Neuroprotection for acute stroke: making clinical trials work. Stroke (1999) 1.07
The experiences of an acute stroke unit--implications for multicentre acute stroke trials. J Neurol Neurosurg Psychiatry (1993) 1.06
Effects of angiotensin converting enzyme inhibitor, perindopril, on autonomic reflexes. Eur J Clin Pharmacol (1986) 1.05
A real time 2-dimensional ultrasonic scanner for clinical use. Ultrasonics (1976) 1.04
The apolipoprotein E epsilon4 allele and outcome in cerebrovascular disease. Stroke (1998) 1.03
Peroneal stimulator; evaluation for the correction of spastic drop foot in hemiplegia. Arch Phys Med Rehabil (1996) 1.03
Mistyping of the human angiotensin-converting enzyme gene polymorphism: frequency, causes and possible methods to avoid errors in typing. J Mol Endocrinol (1996) 1.03
The prognostic value of the components of the Glasgow Coma Scale following acute stroke. QJM (2003) 1.03
Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study. J Med Chem (1999) 1.03
Haemodynamic and humoral effects of oral perindopril, an angiotensin converting enzyme inhibitor, in man. Br J Clin Pharmacol (1987) 1.02
Feasibility and safety of norepinephrine-induced arterial hypertension in acute ischemic stroke. Neurology (2004) 1.01
Two-dimensional echocardiography with a wide angle (60 degrees) sector scanner. Br Heart J (1977) 1.01
Effect of apolipoprotein E genotype on in-hospital mortality following intracerebral haemorrhage. Acta Neurol Scand (2003) 1.00
Dose optimization of intravenous magnesium sulfate after acute stroke. Stroke (1998) 1.00
Differences in first dose response to angiotensin converting enzyme inhibition in congestive heart failure: a placebo controlled study. Br Heart J (1991) 1.00
Termination of Acute Stroke Studies Involving Selfotel Treatment. ASSIST Steering Committed. Lancet (1997) 0.99
The management of ventricular septal rupture following myocardial infarction. Q J Med (1980) 0.99
Olfaction in patients with suspected parkinsonism and scans without evidence of dopaminergic deficit (SWEDDs). J Neurol Neurosurg Psychiatry (2009) 0.99
A recognition tool for transient ischaemic attack. QJM (2008) 0.99
Perindopril reduces blood pressure but not cerebral blood flow in patients with recent cerebral ischemic stroke. Stroke (1997) 0.98
Statin administration prior to ischaemic stroke onset and survival: exploratory evidence from matched treatment-control study. Eur J Neurol (2005) 0.97
The haemodynamic and humoral effects of treatment for one month with the angiotensin converting enzyme inhibitor perindopril in salt replete hypertensive patients. Eur J Clin Pharmacol (1987) 0.97
Effects of intravenous S-9780, an angiotensin-converting enzyme inhibitor, in normotensive subjects. J Cardiovasc Pharmacol (1987) 0.97
Differentiation between gaseous and formed embolic materials in vivo. Application in prosthetic heart valve patients. Stroke (1994) 0.97
Stroke in pregnancy and the puerperium: what magnitude of risk? J Neurol Neurosurg Psychiatry (1995) 0.96
Prognosis of asymptomatic stenosis of the middle cerebral artery. J Neurol Neurosurg Psychiatry (2004) 0.96
Age and the pharmacokinetics and pharmacodynamics of chronic enalapril treatment. Clin Pharmacol Ther (1987) 0.95
Excitatory amino acid antagonists for acute stroke. Cochrane Database Syst Rev (2003) 0.94
The AMPA antagonist ZK 200775 in patients with acute ischaemic stroke: a double-blind, multicentre, placebo-controlled safety and tolerability study. Cerebrovasc Dis (2005) 0.93
Double blind controlled study of low dose intravenous perindoprilat or enalaprilat infusion in elderly patients with heart failure. Br Heart J (1993) 0.93
Tissue and plasma angiotensin converting enzyme and the response to ACE inhibitor drugs. Br J Clin Pharmacol (1991) 0.93
A randomized, double-blind, placebo-controlled pilot trial of intravenous magnesium sulfate in acute stroke. Stroke (1995) 0.92
Coronary artery disease patients' perception of their health and expectations of benefit following coronary artery bypass grafting. J Adv Nurs (2000) 0.92
Transhemispheric passage of microemboli in patients with unilateral internal carotid artery occlusion. Stroke (1993) 0.92
A prospective evaluation of the Björk-Shiley, Hancock, and Carpentier-Edwards heart valve prostheses. Circulation (1986) 0.92
Assessment of changes in general health status using the short-form 36 questionnaire 1 year following coronary artery bypass grafting. Eur J Cardiothorac Surg (2000) 0.92
Phosphinic peptides as zinc metalloproteinase inhibitors. Cell Mol Life Sci (2004) 0.91
Duration of neuroprotective treatment for ischemic stroke. Stroke (1998) 0.91
Alpha-synuclein in peripheral tissues and body fluids as a biomarker for Parkinson's disease - a systematic review. Acta Neurol Scand (2014) 0.91
The influence of general health status and social support on symptomatic outcome following coronary artery bypass grafting. Heart (2001) 0.91
Perindopril. A review of its pharmacokinetics and clinical pharmacology. Drugs (1990) 0.91